ImmuCell Corporation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
ImmuCell Corporation (ICCC) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of $1.72 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-29.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2018-03-29
- ImmuCell Corporation effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2017 was $1.72K, a 84.04% decline from fiscal 2016.
- ImmuCell Corporation effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2016 was $10.79K, a 81.09% decline from fiscal 2015.
- ImmuCell Corporation effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2015 was $57.08K, a 287.42% increase from fiscal 2014.
- ImmuCell Corporation effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2014 was $14.73K, a 29.70% decline from fiscal 2013.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month as first filed |
|---|---|---|
| 2017-12-31 | $1.72K 10-K · filed 2018-03-29 | |
| 2016-12-31 | $10.79K 10-K · filed 2018-03-29 | |
| 2015-12-31 | $57.08K 10-K · filed 2017-03-30 | |
| 2014-12-31 | $14.73K 10-K · filed 2016-03-25 | |
| 2013-12-31 | $20.96K 10-K · filed 2016-03-25 | |
| 2012-12-31 | $30.34K 10-K · filed 2015-03-26 | $26.21K 10-K · filed 2013-03-28 |
| 2011-12-31 | -$10.27K 10-K · filed 2014-03-26 | $2.24K 10-K · filed 2013-03-28 |
| 2010-12-31 | -$18.16K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |